Drug profile · INN
revefenacin
REVEFENACIN
revefenacin (REVEFENACIN) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — revefenacin
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 10
- Programs
- 3
- Data quality
- 0.84
Quick answer
revefenacin (REVEFENACIN) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M3 antagonist
Primary target: Muscarinic acetylcholine receptor M3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12285417
Methods for treating chronic obstructive pulmonary disease
granted -
US 12048692
Methods for treating chronic obstructive pulmonary disease
granted -
US 11858898
Crystalline freebase forms of a biphenyl compound
granted -
US 11691948
Crystalline freebase forms of a biphenyl compound
granted -
US 11484531
Methods for treating chronic obstructive pulmonary disease
granted -
US 11008289
Crystalline freebase forms of a biphenyl compound
granted -
US 10550081
Crystalline freebase forms of a biphenyl compound
granted -
US 9765028
Crystalline freebase forms of a biphenyl compound
granted -
US 8541451
Crystalline freebase forms of a biphenyl compound
granted -
US 7288657
Biphenyl compounds useful as muscarinic receptor antagonists
granted
Frequently asked questions
What is revefenacin?
revefenacin (REVEFENACIN) is a muscarinic acetylcholine receptor m3 antagonist. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for revefenacin?
REVEFENACIN is a marketed brand name for revefenacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of revefenacin?
revefenacin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.